Insight Brief
Due Diligence and Quality Systems Integration
Essential M&A steps for the pharmaceutical and medical device industries
Dec 15, 2025
Global trade tensions, supply chain disruptions, and U.S. reshoring initiatives have created unprecedented volatility in the pharmaceutical and medical device industries, driving record M&A and contract manufacturing activity. This article explains why efficient and high-quality Due Diligence (DD) and Quality Systems Integration (QSI) are critical for competitiveness, as companies that act quickly gain market advantage while slower players risk losing share.

Related solutions

Contact Us